ACLS Certification Institute offers ACLS, BLS, PALS, and NRP certification and recertification. These training programs are approved to provide CEU credits in joint partnership with the Postgraduate Institute for Medicine (PIM) and through the Commission on Accreditation for Prehospital Continuing Education (CAPCE).
This activity has been designed to meet the educational needs of healthcare providers involved in the care of patients in cardiac arrest.
Educational ObjectivesEach certification has distinct educational objectives. Please click the provided link for a complete list.
FOR SPECIFIC CREDIT HOUR INFORMATION, PLEASE CLICK THE APPROPRIATE SECTION BELOW.
|Program Name||CAPCE Code||Credit Hours|
|ACLS Certification||17-CSTEP-F3-0001||8 hours|
|ACLS Recertification||17-CSTEP-F3-0002||4 hours|
|BLS Certification||17-CSTEP-F3-0003||4 hours|
|BLS Recertification||17-CSTEP-F3-0004||2 hours|
|PALS Certification||17-CSTEP-F3-0005||8 hours|
|PALS Recertification||17-CSTEP-F3-0006||4 hours|
|Neonatal Resuscitation Certification||17-CSTEP-F3-0007||8 hours|
|Neonatal Resuscitation Recertification||17-CSTEP-F3-0008||4 hours|
CAPCE represents only that its accredited programs have met CAPCE’s standards for accreditation. These standards require sound educational offerings determined by a review of its objectives, teaching plan, faculty, and program evaluation processes. CAPCE does not endorse or support the actual teachings, opinions or material content as presented by the speaker(s) and/or sponsoring organization. CAPCE accreditation does not represent that the content conforms to any national, state or local standard or best practice of any nature. No student shall have any cause of action against CAPCE based on the accreditation of the material.
|PROGRAM NAME||CREDIT HOURS|
|ACLS Certification||8.0 AMA PRA Category 1 Credit(s)™|
|ACLS Recertification||4.0 AMA PRA Category 1 Credit(s)™|
|BLS Certification||4.0 AMA PRA Category 1 Credit(s)™|
|BLS Recertification||2.0 AMA PRA Category 1 Credit(s)™|
|PALS Certification||8.0 AMA PRA Category 1 Credit(s)™|
|PALS Recertification||4.0 AMA PRA Category 1 Credit(s)™|
|Neonatal Resuscitation Certification||8.0 AMA PRA Category 1 Credit(s)™|
|Neonatal Resuscitation Recertification||4.0 AMA PRA Category 1 Credit(s)™|
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|Program Name||Credit Hours||Code Number||Expiration Date|
|Advanced Cardiac Life Support (ACLS) - Provider Course||8.00 Class A CE Credits||1033980||10/31/2017|
|Advanced Cardiac Life Support (ACLS) - Recertification||4.00 Class A CE Credits||1033981||10/31/2017|
|Pediatric Advanced Life Support (PALS) - Provider Course||8.00 Class A CE Credits||1033978||10/31/2017|
|Pediatric Advanced Life Support (PALS) - Recertification||4.00 Class A CE Credits||1033979||10/31/2017|
|Neonatal Resuscitation Programs (NRP) - Provider Course||8.00 Class A CE Credits||1033982||10/31/2017|
|Neonatal Resuscitation Programs (NRP) - Recertification||4.00 Class A CE Credits||1033974||10/31/2017|
These programs have been prior approved by the American Association of Nurse Anethetists for Class A CE credits.
Effective May 1, 2013, the AANA does not award CME credits for BLS certification or recertification courses. This change was made in response to a revision by the American Nurses Credentialing Centers (ANCC) with the goal of providing quality educational offerings that provide CRNAs supplemental courses that meet their level of licensure.
|PROGRAM NAME||CREDIT HOURS|
|ACLS Certification||8 hours|
|ACLS Recertification||4 hours|
|BLS Certification||4 hours|
|BLS Recertification||2 hours|
|PALS Certification||8 hours|
|PALS Recertification||4 hours|
|Neonatal Resuscitation Certification||8 hours|
|Neonatal Resuscitation Recertification||4 hours|
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
|PROGRAM NAME||CREDIT HOURS|
|ACLS Certification||8 ADA credits|
|ACLS Recertification||4 ADA credits|
|BLS Certification||4 ADA credits|
|BLS Recertification||2 ADA credits|
|PALS Certification||8 ADA credits|
|PALS Recertification||4 ADA credits|
|Neonatal Resuscitation Certification||8 ADA credits|
|Neonatal Resuscitation Recertification||4 ADA credits|
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.
Concerns or complaints about a CE Provider may be directed to the provider or to ADA CERP at www.ada.org/cerp.
The Postgraduate Institute of Medicine designates each of the following continuing education activities for the associated number of contact hours through the Accreditation Council for Pharmacy Education.
|Program Name||Contact Hours||Universal Activity Number|
|ACLS Certification||8 hours (0.80 CEUs)||809-999-16-215-H01-P|
|ACLS Recertification||4 hours (0.40 CEUs)||809-999-16-216-H01-P|
|BLS Certification||4 hours (0.40 CEUs)||809-999-16-217-H01-P|
|BLS Recertification||2 hours (0.20 CEUs)||809-999-16-218-H01-P|
|PALS Certification||8 hours (0.80 CEUs)||809-999-16-219-H01-P|
|PALS Recertification||4 hours (0.40 CEUs)||809-999-16-220-H01-P|
|Neonatal Resuscitation Certification||8 hours (0.80 CEUs)||809-999-16-221-H01-P|
|Neonatal Resuscitation Recertification||4 hours (0.40 CEUs)||809-999-16-222-H01-P|
The Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest or a commercial interest.
The ACLS Certification Institute faculty—Christopher J. Bosche, Mark Dzwonkiewicz, Jason Haag, Will B. Hendon, Judson Smith, and Janet Taylor—hereby state that they or their spouse/life partner have no financial relationships, relationships to products or devices, or other commercial interests related to the content of this CME activity of any amount during the past 12 months.
The PIM planners and managers—Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP—hereby state that they or their spouse/life partner have no financial relationships, relationships to products or devices, or other commercial interests related to the content of this CME activity of any amount during the past 12 months.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.